Literature DB >> 24059239

Alzheimer´s disease and oxidative stress: a review.

Miroslav Pohanka1.   

Abstract

Alzheimer´s disease (AD) is a neurodegenerative disorder with no known cure and rapid rise in incidence. The predominant cognitive impairment is currently treated using cognitive enhancers like cholinesterase inhibitors. The two molecular hallmarks of AD are amyloid plaques created from an amyloid precursor protein and hyperphosphorylated tau protein that is deposited as neurofibrillary tangles inside neurons. A number of pathological mechanisms follow or precede these formations. Alteration in mitochondrial function and deposition of heavy metals are reported. The disease progression is enhanced by oxidative stress. However, the role of oxidative stress is not universally accepted. The current review covers and discusses the basic evidence and role of oxidative stress in AD development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24059239     DOI: 10.2174/09298673113206660258

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  44 in total

1.  Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.

Authors:  Patricia Del Cerro; Carolina Alquézar; Fernando Bartolomé; Pedro González-Naranjo; Concepción Pérez; Eva Carro; Juan A Páez; Nuria E Campillo; Ángeles Martín-Requero
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

2.  Verapamil Inhibits Ser202/Thr205 Phosphorylation of Tau by Blocking TXNIP/ROS/p38 MAPK Pathway.

Authors:  Mariarosa Anna Beatrice Melone; Clemente Dato; Simona Paladino; Cinzia Coppola; Claudia Trebini; Maria Teresa Giordana; Lorena Perrone
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

3.  Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study.

Authors:  Galit Weinstein; Kendra Davis-Plourde; Jayandra J Himali; Shira Zelber-Sagi; Alexa S Beiser; Sudha Seshadri
Journal:  Liver Int       Date:  2019-06-26       Impact factor: 5.828

4.  Actovegin reduces the hydrogen peroxide-induced cell apoptosis of SK-N-SH neuroblastoma by means of p38MAPK and PI-3K inhibition.

Authors:  M M Yurinskaya; M G Vinokurov; S V Grachev; E I Astashkin
Journal:  Dokl Biol Sci       Date:  2014-07-02

5.  Increased susceptibility to oxidative death of lymphocytes from Alzheimer patients correlates with dementia severity.

Authors:  Daniela P Ponce; Felipe Salech; Carol D SanMartin; Monica Silva; Chengjie Xiong; Catherine M Roe; Mauricio Henriquez; Andrew F Quest; Maria I Behrens
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

6.  Proteomics and bioinformatics analysis of mouse hypothalamic neurogenesis with or without EPHX2 gene deletion.

Authors:  Lijun Zhong; Juntuo Zhou; Dawei Wang; Xiajuan Zou; Yaxin Lou; Dan Liu; Bin Yang; Yi Zhu; Xiaoxia Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Activator protein-1 (AP-1): a bridge between life and death in lung epithelial (A549) cells under hypoxia.

Authors:  Seema Yadav; Namita Kalra; Lilly Ganju; Mrinalini Singh
Journal:  Mol Cell Biochem       Date:  2017-06-06       Impact factor: 3.396

8.  Protection of the Crayfish Mechanoreceptor Neuron and Glial Cells from Photooxidative Injury by Modulators of Diverse Signal Transduction Pathways.

Authors:  Anatoly Uzdensky; Elena Berezhnaya; Andrej Khaitin; Vera Kovaleva; Maxim Komandirov; Maria Neginskaya; Mikhail Rudkovskii; Svetlana Sharifulina
Journal:  Mol Neurobiol       Date:  2015-10       Impact factor: 5.590

Review 9.  Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.

Authors:  Sandeep Kumar Singh; Saurabh Srivastav; Rudolph J Castellani; Germán Plascencia-Villa; George Perry
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 10.  Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.

Authors:  Hong Lian; Hui Zheng
Journal:  J Neurochem       Date:  2015-11-30       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.